Brief: Eton Pharmaceuticals Awarded U.S. Patent For Proprietary Hydrocortisone Oral Liquid Formulation
21/02/2024 14:27
Feb 21 (Reuters) - Eton Pharmaceuticals Inc ETON.O :
* ETON PHARMACEUTICALS AWARDED U.S. PATENT FOR PROPRIETARY
HYDROCORTISONE ORAL LIQUID FORMULATION
Source text for Eikon: ID:nGNXH3jPt
Further company coverage: ETON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eton Pharmaceuticals
See all newsBrief: Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - SEC Filing
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer